Immunome (NASDAQ:IMNM) reported quarterly losses of $(0.15) per share which beat the analyst consensus estimate of $(0.28) by 46.43 percent. This is a 76.56 percent increase over losses of $(0.64) per share from the same period last year. The company reported quarterly sales of $3.83 million which beat the analyst consensus estimate of $2.07 million by 84.83 percent.
enCore Energy (AMEX:EU) reported quarterly losses of $(0.06) per share.
Trading Halt: Halted at 7:50:00 P.m. ET - Trading Halt: Halt News Pending
OCR is headquartered in Rockville, Maryland. OCR is a provider of global trade compliance solutions and content. OCR's controlled exports data expands Descartes' extensive global trade content library for customers and partners, such as SAP and Oracle.
Tricon Shareholders Vote To Approve Proposed Take Private By Blackstone Real Estate
HarborOne Bancorp Appoints Stephen W. Finocchio As Executive Vice President And CFO
Nuvve Holdings Shares Are Trading Lower After the Company Reported Worse-than-expected Q4 Financial Results
Surf Air Mobility Inc. Common Stock (NYSE:SRFM) reported quarterly losses of $(1.32) per share which missed the analyst consensus estimate of $(0.28) by 371.43 percent. The company reported quarterly sales of $26.84 million which beat the analyst consensus estimate of $25.69 million by 4.46 percent.
Applied Therapeutics Shares Are Trading Lower After the Company Announced That the FDA Extended the Review Period for the NDA for Govorestat for the Treatment of Classic Galactosemia by Three Months
PureCycle currently plans to provide an update on the outcome of the pause during the company's next corporate update in May.
Cheche Group Partners With Xiaomi Group; Cheche To Provide Auto Insurance Service Solution To Car Owners In Multiple Cities In China
With an expanded product selection, the new mandate for Overstock.com is the "crazy good deals" – up to 30-70% off.
DWS Municipal Income Trust Terminates Of Fund; To Make Liquidating Distribution To Shareholders And Distribution Rate Increase
DWS Strategic Municipal Income Trust Approved Termination And Will Make Liquidating Distribution To Shareholders
Cartesian Therapeutics Shares Are Trading Lower. The Company Announced Approval of Conversion of Series A Convertible Preferred Stock and Plans to Effect a Reverse Stock Split
Oxform Industries Shares Are Trading Lower After the Company Reported Worse-than-expected Q4 Financial Results and Issued Weak Q1 Guidance
Pulse Biosciences Shares Are Trading Lower After the Company Reported Q4 Financial Results. Also, the Company Announced Plans to Initiate a Rights Offering of up to $60 Million Worth of Units
Pulse Biosciences (NASDAQ:PLSE) reported quarterly losses of $(0.22) per share. This is a 12 percent increase over losses of $(0.25) per share from the same period last year.
Oxford Industries Sees Q1 2024 Adj. EPS $2.60-$2.80 Vs $3.58 Est.; Revenue $395M-$415M Vs $419.196M Est
Oxford Industries Sees FY24 Adj. EPS $9.30-$9.70 Vs $10.21 Est.; Revenue $1.63B-$1.67B Vs $1.575B Est
Helius Medical Tech (NASDAQ:HSDT) reported quarterly losses of $(1.47) per share which beat the analyst consensus estimate of $(3.77) by 61.01 percent. The company reported quarterly sales of $134.000 thousand which missed the analyst consensus estimate of $246.333 thousand by 45.60 percent. This is a 52.48 percent decrease over sales of $282.000 thousand the same period last year.
Ascent Industries (NASDAQ:ACNT) reported quarterly losses of $(0.73) per share. The company reported quarterly sales of $41.216 million which missed the analyst consensus estimate of $63.500 million by 35.09 percent. This is a 23.93 percent decrease over sales of $54.180 million the same period last year.
Bhisham Khare Reports 9.83% Stake In Aeries Technology
Tang Capital Partners Discloses 9.99% Passive Stake In Outlook Therapeutics
Oxford Industries (NYSE:OXM) reported quarterly earnings of $1.90 per share which missed the analyst consensus estimate of $1.95 by 2.56 percent.
Robert Duggan, the Company's Executive Chairman and majority stockholder, has indicated his support for the rights offering and his intent to participate in the rights offering on the same terms as all other investors.
Sharecare Says Given The Strategic Review Process Is Ongoing, Among Other Factors, The Company Will Not Provide Financial Guidance For The Quarter Ending March 31, 2024, Or Fiscal Year 2024, At This Time
Torrid Sees Q1 Net Sales $277M-$282M Vs $296.44M Est., Sees FY24 Net Sales $1.135B-$1.155B Vs $1.14B Est
Torrid Holdings (NYSE:CURV) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.07) by 42.86 percent. The company reported quarterly sales of $293.500 million which beat the analyst consensus estimate of $274.827 million by 6.79 percent.
Eledon Pharma (NASDAQ:ELDN) reported quarterly losses of $(0.32) per share which beat the analyst consensus estimate of $(0.39) by 17.95 percent.